Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Clinical Pharmacology and Therapeutics
|
July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy
Julio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
Michael T Eadon, David W Hein, Michael A Andersen, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
Julio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Blood
|
November 12, 2020
IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias
Akash Gupta, Yu-Dong Fei, Tae Yun Kim, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Clinical Pharmacology and Therapeutics
|
July 2, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy
Julio D Duarte, Cameron D Thomas, Craig R Lee, et al.
Clinical Pharmacology and Therapeutics
|
September 20, 2025
Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy
Michael T Eadon, David W Hein, Michael A Andersen, et al.
Journal of the American Heart Association
|
June 14, 2024
<i>CYP2C19</i> Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.
Clinical Pharmacology and Therapeutics
|
October 28, 2022
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y<sub>12</sub> Inhibitor Prescribing After Percutaneous Coronary Intervention
Larisa H Cavallari, Nita A Limdi, Amber L Beitelshees, et al.
Journal of the American College of Cardiology
|
April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y<sub>12</sub> Inhibitors Based on the ABCD-GENE Score
Cameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
July 20, 2021
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
Julio D Duarte, Rachel Dalton, Amanda L Elchynski, et al.
Journal of the American Heart Association
|
February 14, 2022
<i>CYP2C19</i> Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
Clinical Pharmacology and Therapeutics
|
September 8, 2020
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
Craig R Lee, Cameron D Thomas, Amber L Beitelshees, et al.
Blood
|
November 12, 2020
IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias
Akash Gupta, Yu-Dong Fei, Tae Yun Kim, et al.
Clinical Pharmacology and Therapeutics
|
December 28, 2017
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy
Philip E Empey, James M Stevenson, Sony Tuteja, et al.
Page
of 8